• Return to Headlines

CR Bard Up 41.8% Since SmarTrend Uptrend Call (BCR)

By James Quinn

SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on December 23rd, 2016 at $222.45. In approximately 6 months, CR Bard has returned 41.80% as of today's recent price of $315.44.

In the past 52 weeks, CR Bard share prices have been bracketed by a low of $166.29 and a high of $315.53 and are now at $315.44, 90% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 0.9%.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard markets vascular, urological, oncological, and surgical specialties products.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of CR Bard shares.

Log in and add CR Bard (BCR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights cr bard

Ticker(s): BCR